| Financial Year |
March 31 2023 |
| Monetary Funds |
652,350,991.16 |
| Held-for-trading Financial Assets |
7,278,024.80 |
| Notes Receivable |
686,121.32 |
| Accounts Receivable |
346,130,541.42 |
| Advances to Suppliers |
27,414,476.86 |
| Other Receivables |
11,669,080.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
3,768,059.24 |
| Dividend Receivable |
-- |
| Inventories |
364,056,453.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
84,092,368.23 |
| Total Current Assets |
1,524,197,454.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
3,559,628.11 |
| Fixed Assetes |
1,037,944,043.74 |
| Under-construction Projects |
27,077,078.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
250,682,639.61 |
| R&D expenses |
-- |
| Goodwill |
5,055,070.20 |
| Long-Term Deferred and Prepaid Expenses |
18,041,707.38 |
| Deferred Income Tax Assets |
6,144,535.82 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,365,258,159.36 |
| Total Assets |
2,889,455,613.64 |
| Short-Term Loans |
336,326,302.75 |
| Trading Financial liabilities |
-- |
| Notes Payable |
129,912,147.62 |
| Accounts Payable |
379,715,468.22 |
| Accounts Received In Advance |
1,292,706.48 |
| Employee Compensation Payable |
56,303,593.70 |
| Taxes Payable |
15,968,608.37 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
22,114,961.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,030,469.72 |
| Other Current Liabilities |
27,522,675.47 |
| Sub-Total of Current Liabilities |
986,482,093.02 |
| Long-term Loans |
50,194,444.45 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,467,619.44 |
| Deferred Income Tax Liabilities |
22,206,396.18 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
81,350,803.57 |
| Total Liabilities |
1,067,832,896.59 |
| Paid-In Capital(Or Share Stock) |
302,512,640.00 |
| Capital Surplus |
565,477,239.14 |
| Surplus Reserve |
117,749,138.73 |
| LESS:Treasury Stock |
45,007,031.20 |
| Undistributed Profits |
869,297,761.93 |
| Minority Stockholder's Interest |
13,960,057.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,807,662,659.99 |
| Owner's Equity（Stockholder's Equity） |
1,821,622,717.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,889,455,613.64 |
